EP2918300 - Syringe with disabling mechanism [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 11.06.2021 Database last updated on 31.08.2024 | |
Former | The patent has been granted Status updated on 03.07.2020 | ||
Former | Grant of patent is intended Status updated on 23.02.2020 | ||
Former | Examination is in progress Status updated on 10.11.2017 | Most recent event Tooltip | 17.06.2022 | Lapse of the patent in a contracting state New state(s): CY, HU, MT, TR | published on 20.07.2022 [2022/29] | Applicant(s) | For all designated states Becton, Dickinson and Company 1 Becton Drive Franklin Lakes, NJ 07417-1880 / US | [2016/49] |
Former [2015/38] | For all designated states Becton Dickinson and Company One Becton Drive Franklin Lakes, NJ 07417-1880 / US | Inventor(s) | 01 /
Caizza, Richard J. One Cherry Tree Road NJ, 07462 Vernon / US | 02 /
Odell, Robert 357 Pulis Avenue NJ, 07417 Franklin Lakes / US | 03 /
Wayman, Brian H. 27 Sherman Avenue NJ, 07950 Morris Plains / US | [2015/38] | Representative(s) | dompatent von Kreisler Selting Werner - Partnerschaft von Patent- und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE | [2020/32] |
Former [2015/38] | Von Kreisler Selting Werner - Partnerschaft von Patentanwälten und Rechtsanwälten mbB Deichmannhaus am Dom Bahnhofsvorplatz 1 50667 Köln / DE | Application number, filing date | 15155446.6 | 31.10.2008 | [2015/38] | Priority number, date | US20080137732 | 12.06.2008 Original published format: US 137732 | [2015/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP2918300 | Date: | 16.09.2015 | Language: | EN | [2015/38] | Type: | B1 Patent specification | No.: | EP2918300 | Date: | 05.08.2020 | Language: | EN | [2020/32] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 09.06.2015 | Classification | IPC: | A61M5/50, A61M5/315 | [2015/38] | CPC: |
A61M5/502 (EP,US);
A61M5/3286 (KR);
A61M5/315 (KR);
A61M5/5066 (EP,US);
A61M2005/31516 (EP,US);
A61M2005/5026 (EP,US);
A61M2005/5073 (EP,US)
(-)
| Designated contracting states | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR [2016/17] |
Former [2015/38] | AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MT, NL, NO, PL, PT, RO, SE, SI, SK, TR | Title | German: | Spritze mit Deaktivierungsmechanismus | [2015/38] | English: | Syringe with disabling mechanism | [2015/38] | French: | Seringue avec mécanisme de neutralisation | [2015/38] | Examination procedure | 15.03.2016 | Amendment by applicant (claims and/or description) | 15.03.2016 | Examination requested [2016/17] | 14.11.2017 | Despatch of a communication from the examining division (Time limit: M04) | 16.03.2018 | Reply to a communication from the examining division | 24.02.2020 | Communication of intention to grant the patent | 24.06.2020 | Fee for grant paid | 24.06.2020 | Fee for publishing/printing paid | 24.06.2020 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP08874649.0 / EP2318077 | Opposition(s) | 07.05.2021 | No opposition filed within time limit [2021/28] | Fees paid | Renewal fee | 17.02.2015 | Renewal fee patent year 03 | 17.02.2015 | Renewal fee patent year 04 | 17.02.2015 | Renewal fee patent year 05 | 17.02.2015 | Renewal fee patent year 06 | 17.02.2015 | Renewal fee patent year 07 | 26.10.2015 | Renewal fee patent year 08 | 25.10.2016 | Renewal fee patent year 09 | 23.10.2017 | Renewal fee patent year 10 | 26.10.2018 | Renewal fee patent year 11 | 21.10.2019 | Renewal fee patent year 12 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 31.10.2008 | AT | 05.08.2020 | CY | 05.08.2020 | CZ | 05.08.2020 | DK | 05.08.2020 | EE | 05.08.2020 | FI | 05.08.2020 | HR | 05.08.2020 | LT | 05.08.2020 | LV | 05.08.2020 | MC | 05.08.2020 | MT | 05.08.2020 | NL | 05.08.2020 | PL | 05.08.2020 | RO | 05.08.2020 | SE | 05.08.2020 | SI | 05.08.2020 | SK | 05.08.2020 | TR | 05.08.2020 | CH | 31.10.2020 | LI | 31.10.2020 | LU | 31.10.2020 | BG | 05.11.2020 | NO | 05.11.2020 | GR | 06.11.2020 | IS | 05.12.2020 | PT | 07.12.2020 | [2022/27] |
Former [2021/37] | AT | 05.08.2020 | |
CZ | 05.08.2020 | ||
DK | 05.08.2020 | ||
EE | 05.08.2020 | ||
FI | 05.08.2020 | ||
HR | 05.08.2020 | ||
LT | 05.08.2020 | ||
LV | 05.08.2020 | ||
MC | 05.08.2020 | ||
NL | 05.08.2020 | ||
PL | 05.08.2020 | ||
RO | 05.08.2020 | ||
SE | 05.08.2020 | ||
SI | 05.08.2020 | ||
SK | 05.08.2020 | ||
CH | 31.10.2020 | ||
LI | 31.10.2020 | ||
LU | 31.10.2020 | ||
BG | 05.11.2020 | ||
NO | 05.11.2020 | ||
GR | 06.11.2020 | ||
IS | 05.12.2020 | ||
PT | 07.12.2020 | ||
Former [2021/36] | AT | 05.08.2020 | |
CZ | 05.08.2020 | ||
DK | 05.08.2020 | ||
EE | 05.08.2020 | ||
FI | 05.08.2020 | ||
HR | 05.08.2020 | ||
LT | 05.08.2020 | ||
LV | 05.08.2020 | ||
MC | 05.08.2020 | ||
NL | 05.08.2020 | ||
PL | 05.08.2020 | ||
RO | 05.08.2020 | ||
SE | 05.08.2020 | ||
SI | 05.08.2020 | ||
SK | 05.08.2020 | ||
LU | 31.10.2020 | ||
BG | 05.11.2020 | ||
NO | 05.11.2020 | ||
GR | 06.11.2020 | ||
IS | 05.12.2020 | ||
PT | 07.12.2020 | ||
Former [2021/31] | AT | 05.08.2020 | |
CZ | 05.08.2020 | ||
DK | 05.08.2020 | ||
EE | 05.08.2020 | ||
FI | 05.08.2020 | ||
HR | 05.08.2020 | ||
LT | 05.08.2020 | ||
LV | 05.08.2020 | ||
MC | 05.08.2020 | ||
NL | 05.08.2020 | ||
PL | 05.08.2020 | ||
RO | 05.08.2020 | ||
SE | 05.08.2020 | ||
SK | 05.08.2020 | ||
LU | 31.10.2020 | ||
BG | 05.11.2020 | ||
NO | 05.11.2020 | ||
GR | 06.11.2020 | ||
IS | 05.12.2020 | ||
PT | 07.12.2020 | ||
Former [2021/28] | AT | 05.08.2020 | |
CZ | 05.08.2020 | ||
DK | 05.08.2020 | ||
EE | 05.08.2020 | ||
FI | 05.08.2020 | ||
HR | 05.08.2020 | ||
LT | 05.08.2020 | ||
LV | 05.08.2020 | ||
NL | 05.08.2020 | ||
PL | 05.08.2020 | ||
RO | 05.08.2020 | ||
SE | 05.08.2020 | ||
SK | 05.08.2020 | ||
BG | 05.11.2020 | ||
NO | 05.11.2020 | ||
GR | 06.11.2020 | ||
IS | 05.12.2020 | ||
PT | 07.12.2020 | ||
Former [2021/22] | AT | 05.08.2020 | |
CZ | 05.08.2020 | ||
DK | 05.08.2020 | ||
EE | 05.08.2020 | ||
FI | 05.08.2020 | ||
HR | 05.08.2020 | ||
LT | 05.08.2020 | ||
LV | 05.08.2020 | ||
NL | 05.08.2020 | ||
PL | 05.08.2020 | ||
RO | 05.08.2020 | ||
SE | 05.08.2020 | ||
BG | 05.11.2020 | ||
NO | 05.11.2020 | ||
GR | 06.11.2020 | ||
IS | 05.12.2020 | ||
PT | 07.12.2020 | ||
Former [2021/20] | AT | 05.08.2020 | |
DK | 05.08.2020 | ||
FI | 05.08.2020 | ||
HR | 05.08.2020 | ||
LT | 05.08.2020 | ||
LV | 05.08.2020 | ||
NL | 05.08.2020 | ||
PL | 05.08.2020 | ||
SE | 05.08.2020 | ||
BG | 05.11.2020 | ||
NO | 05.11.2020 | ||
GR | 06.11.2020 | ||
IS | 05.12.2020 | ||
PT | 07.12.2020 | ||
Former [2021/12] | AT | 05.08.2020 | |
FI | 05.08.2020 | ||
HR | 05.08.2020 | ||
LT | 05.08.2020 | ||
LV | 05.08.2020 | ||
NL | 05.08.2020 | ||
PL | 05.08.2020 | ||
SE | 05.08.2020 | ||
BG | 05.11.2020 | ||
NO | 05.11.2020 | ||
GR | 06.11.2020 | ||
IS | 05.12.2020 | ||
PT | 07.12.2020 | ||
Former [2021/10] | AT | 05.08.2020 | |
FI | 05.08.2020 | ||
HR | 05.08.2020 | ||
LT | 05.08.2020 | ||
LV | 05.08.2020 | ||
PL | 05.08.2020 | ||
SE | 05.08.2020 | ||
BG | 05.11.2020 | ||
NO | 05.11.2020 | ||
GR | 06.11.2020 | ||
IS | 05.12.2020 | ||
PT | 07.12.2020 | ||
Former [2021/09] | AT | 05.08.2020 | |
FI | 05.08.2020 | ||
LT | 05.08.2020 | ||
SE | 05.08.2020 | ||
BG | 05.11.2020 | ||
NO | 05.11.2020 | ||
GR | 06.11.2020 | ||
PT | 07.12.2020 | ||
Former [2021/08] | FI | 05.08.2020 | |
LT | 05.08.2020 | ||
SE | 05.08.2020 | ||
BG | 05.11.2020 | ||
NO | 05.11.2020 | ||
PT | 07.12.2020 | ||
Former [2021/07] | FI | 05.08.2020 | |
LT | 05.08.2020 | ||
NO | 05.11.2020 | Documents cited: | Search | [XY]WO2004045683 (DUGMORE PETER BALFOUR [ZA], et al) [X] 1 * abstract * [Y] 2-18; | [XY]EP0340899 (FARBSTEIN DAVID [IL], et al) [X] 1 * abstract * [Y] 2-18; | [E]WO2008154616 (BECTON DICKINSON CO [US], et al) [E] 1-18 * figures 4,6,11,16-18,26,27 *; | [XY]WO9003818 (AGVEN MEDICAL CORP [GB]) [X] 1 * figures 1-4 * [Y] 2-18 | Examination | US2004176722 |